LP220250-7
Ombitasvir
Active
Description
Ombitasvir (ABT-267) is a hepatitis C virus (HCV) NS5A inhibiting antiviral drug for the treatment of HCV infection. PMID: 25451055. United States FDA approved ombitasvir-paritaprevir-ritonavir and dasabuvir for the treatment of genotype 1 chronic hepatitis C infection in adults, including patients with compensated cirrhosis. Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Ombitasvir
- Part Display Name
- Ombitasvir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- Ombitasvir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 翁比他韦 Synonyms: CAS 1258226-87-7; |
| es-ES | Spanish (Spain) | Ombitasvir |
| it-IT | Italian (Italy) | Ombitasvir |
| fr-FR | French (France) | Ombitasvir |
| pl-PL | Polish (Poland) | Ombitaswir |
| el-GR | Greek (Greece) | Ομπιτασβίρη Synonyms: Ομπιτασβίρη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://